Sales of imaging machines were $12.69 billion in 2010, up from $11.78 billion in 2009 in the US. The US market for medical imaging devices is projected to reach about $37.0 billion by 2015. The global market for imaging components was worth $40.4 billion in 2007 and is expected to grow to $58.7 billion by 2012.

MRI is the fastest growing imaging modality with a compound annual growth rate of 9.8% during the period 2005-2015. ALIPs IMASI & EMASI Technologies will exceed the performance of all technologies with the advantages of spectrometry which will be the next revolution in Medical Imaging systems since the arrival of MRI and PET.

Safety and resolution in medical devices is the measure that people in the medical imaging industry are looking for. The use of current imaging devices leads to the exposure of dangerous radiation which results in an accumulative risk for Cancer.

Medical Imaging technologies such as MRI, CT-Scan and X-Ray have both benefits and risks. The benefits are the use of non-invasive diagnostics and an increased number of early cancer detections. However the risk is in these devices that can not be overlooked which is that they expose the patient to the highest dose of radiation leading to long term harmful effects. Therefore the market is in need of a safer medical imaging technology.

According to a report by National Radiation and Protection Council (2009), the total US population affected by exposure to high level radiation has doubled. Concerns were raised about the risk of these devices since the ionizing radiation can cause damage to DNA which leads to cancer and other terminal diseases. Simply put the more radiation you receive the greater your chances that you will get cancer.

Contact us for full report